Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

LSE:RENX Shares Jump 12.99%: KidneyIntelX Growth Story Puts Renalytix Back on Investors’ Radar

Renalytix has moved sharply higher, withLSE:RENX gaining 12.99% on 24 August 2026.

Ankur Sharma | 24 August 2026

Abingdon Health PLC Gains 4.55% as Revenue Momentum and Profitability Progress Strengthen Investor Optimism

The 4.55% rise in Abingdon Health shares was likely supported by the company’s recent trading update, which indicated strong revenue growth and progress toward sustainable profitability. Growth accelerated during the latter part of the period, with contract development work emerging as an important contributor.

Ankur Sharma | 24 August 2026

CRISM Therapeutics Corporation Gains 4.89% as Patient Recruitment Opens for ChemoSeed Glioblastoma Study

CRISM Therapeutics Corporation (LSE:CRTX) is a UK clinical-stage drug-delivery company developing implantable products for the localised and sustained delivery of chemotherapy. Its proprietary ChemoSeed technology is intended to deliver therapeutic concentrations directly into solid tumours or the tissue surrounding a surgically removed tumour.

Ankur Sharma | 24 August 2026

Hemogenyx Pharmaceuticals Plc (LSE:HEMO) Gains 5.89% as European CAR-T Partnerships Strengthen Clinical and Commercial Optimism

Hemogenyx Pharmaceuticals Plc is a clinical-stage biopharmaceutical company developing treatments for blood cancers, bone-marrow disorders and severe immune-related diseases. Its lead candidate, HG-CT-1, is a personalised CAR-T cell therapy designed to target a protein commonly expressed on malignant cells in acute myeloid leukaemia and …

Ankur Sharma | 24 August 2026

Allergy Therapeutics plc (LSE:AGY) Advances 7.84% as Commercial Momentum and Clinical Progress Lift Investor Optimism

Allergy Therapeutics plc is an international commercial biotechnology company focused on the diagnosis and treatment of allergic disorders. Its portfolio includes injectable immunotherapies for pollen, venom and other allergies, alongside a clinical pipeline targeting food allergies. The company sells proprietary and third-party products through …

Ankur Sharma | 24 August 2026

EDX Medical Group Shares Surge 28.21% as Fresh Funding and Health-Screening Expansion Fuel Investor Optimism

EDX Medical Group PLC develops and supplies advanced diagnostic products and digitally enabled healthcare services designed to improve disease detection and support personalised treatment. The recent share-price strength appears to reflect a combination of fresh growth capital, progress with prospective employer contracts and confidence …

Ankur Sharma | 24 August 2026

LSE:MPAL share price drops 2.50%: MedPal AI revenue growth, eMARx and GLP-1 opportunity in focus

MedPal AI LSE:MPAL was in focus on 21 August 2026 after the shares declined2.50% to approximately 3.90p.

Ankur Sharma | 24 August 2026

NAHL Group Stock Falls on 21 August 2026: Earnings, Cash Flow and Strategic Outlook

NAHL Group Plc became a notable mover among UK-listed small-cap stocks on 21 August 2026 after its shares fell4.02%. The decline has drawn attention because the company had recently delivered an encouraging first-half trading update, with revenue, underlying operating profit and free cash flow …

Ankur Sharma | 24 August 2026

Allergy Therapeutics LSE:AGY falls 2.86%: Investors watch Grassmuno, revenue growth and FY2027 outlook

Allergy Therapeutics LSE:AGY was in focus on 21 August 2026 after the shares declined2.86%, closing at approximately5.10p, compared with 5.25p previously. The stock opened around 5.25p and traded in a relatively wide range during the session, illustrating the limited liquidity that can affect the …

Ankur Sharma | 24 August 2026

LSE:BVXP share price drops 2.78%: Bioventix growth outlook, dividends and neurology pipeline in focus

Bioventix LSE:BVXP was firmly in focus on 21 August 2026 after the shares declined2.78%, ending the session around1,750p.

Ankur Sharma | 24 August 2026
Support

Hi! How can we help you today?

Loading…